Maia Wealth LLC Has $2.06 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Maia Wealth LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 10.7% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,928 shares of the healthcare conglomerate’s stock after buying an additional 380 shares during the quarter. Maia Wealth LLC’s holdings in UnitedHealth Group were worth $2,057,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in UNH. GAMMA Investing LLC raised its stake in UnitedHealth Group by 56,142.1% during the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate’s stock worth $4,344,586,000 after buying an additional 8,280,404 shares during the period. Nuveen LLC acquired a new stake in UnitedHealth Group during the 1st quarter worth $3,846,764,000. Vanguard Group Inc. raised its stake in UnitedHealth Group by 6.6% during the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after buying an additional 5,583,343 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in UnitedHealth Group by 36.6% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate’s stock worth $4,346,712,000 after buying an additional 2,301,010 shares during the period. Finally, Northern Trust Corp increased its holdings in UnitedHealth Group by 12.5% during the 4th quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate’s stock worth $4,807,527,000 after purchasing an additional 1,058,488 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 2.5%

UnitedHealth Group stock opened at $250.74 on Monday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a market capitalization of $227.46 billion, a P/E ratio of 10.86, a PEG ratio of 1.62 and a beta of 0.43. The stock has a 50-day simple moving average of $291.78 and a 200 day simple moving average of $405.18.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 EPS. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 dividend on an annualized basis and a dividend yield of 3.5%. The ex-dividend date was Monday, June 16th. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Analysts Set New Price Targets

UNH has been the subject of a number of research reports. Barclays reiterated an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Oppenheimer lowered their target price on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Raymond James Financial cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a report on Wednesday, May 14th. Truist Financial lowered their target price on UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating for the company in a report on Wednesday, July 16th. Finally, TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective for the company. in a report on Monday, May 19th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $366.52.

Insider Activity at UnitedHealth Group

In related news, Director Kristen Gil purchased 3,700 shares of the business’s stock in a transaction that occurred on Thursday, May 15th. The stock was acquired at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the completion of the purchase, the director owned 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the business’s stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company’s stock, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have purchased 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.